Logan Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Logan Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$121K	–	321
2019 Q4	$121K	Hold	20,000	–	–	0.01%	295
2019 Q3	$72K	Hold	20,000	–	–	﹤0.01%	294
2019 Q2	$54K	Hold	20,000	–	–	﹤0.01%	289
2019 Q1	$59K	Sell	20,000 -40,000	-67%	-$98.3K	﹤0.01%	288
2018 Q4	$95K	Buy	60,000 +15,000	+33%	+$42.4K	0.01%	273
2018 Q3	$166K	Buy	+45,000	New	+$134K	0.01%	289

Logan Capital Management's ACHN Position: Q1 2020 in Review

Logan Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 20,000 shares — an estimated $121K sold.

Logan Capital Management first reported a position in ACHN in Q3 2018 and held it in 6 quarters. The position peaked at $166K in Q3 2018. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Logan Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Logan Capital Management sold 20,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $121K.
Logan Capital Management first reported a position in Achillion Pharmaceuticals in Q3 2018 and held it in 6 quarters.
Logan Capital Management's Achillion Pharmaceuticals position peaked at $166K in Q3 2018.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Logan Capital Management's 13F filing for Q1 2020, filed 14 May 2020.